BACKGROUND: A multicentre European randomized control trial - European Uncomplicated Type B Aortic Repair (EU-TBAR) is being developed to compare pre-emptive thoracic endovascular aortic repair (TEVAR) with custom-made devices versus conventional optimal medical therapy. The pretrial set-up is confluent on different pillars, including evaluation of 1) European activity, trends, and governance; 2) outcome reporting; and 3) cost evaluation. This article aimed to demonstrate the observational cross-sectional survey results from participating centers and highlight the risk assessment, activity, practices, and governance of uncomplicated type B aortic dissection (uTBAD). METHODS: This observational cross-sectional European survey used a questionnaire that examined the understanding, risk assessment, local governance oversight, and clinical activity of uTBAD. The data were collected and managed using Research Electronic Data Capture (REDCap). RESULTS: Out of 43 surveyed surgeons, 37 (86%) responded within a month from 14 European countries. Most reported low annual uTBAD encounters, with autumn being the most common season for cases. Pre-emptive TEVAR was recommended by 43.2% of participants, who favored subacute intervention timing. The Gore TAG was the most used TEVAR device, and custom devices were available for 73% of respondents. Risk factors for uTBAD were ranked, with 'Rapid Aortic Enlargement' deemed most critical. A majority of centers had protocols and multidisciplinary teams, with most having readily available radiology services. Only 45.9% had transfer services to specialized centers. CONCLUSIONS: uTBAD remains a misnomer of a dynamic, ongoing disease process requiring early diagnosis and intervention. Pre-emptive TEVAR in high-risk uTBAD is becoming more common, with encouraging results prompting an expansion of indication criteria to a broader uTBAD population managed conservatively. Nevertheless, further evidence is needed through large randomized controlled trials, mainly European collaboratives, to reach a definitive conclusion on the optimum surgical management of uTBAD.
- MeSH
- aneurysma hrudní aorty * chirurgie diagnostické zobrazování ekonomika MeSH
- časové faktory MeSH
- cévní protézy trendy MeSH
- cévy - implantace protéz * škodlivé účinky přístrojové vybavení trendy ekonomika MeSH
- chirurgové * trendy MeSH
- disekce aorty * chirurgie diagnostické zobrazování ekonomika MeSH
- endovaskulární výkony * škodlivé účinky přístrojové vybavení trendy ekonomika MeSH
- hodnocení rizik MeSH
- lékařská praxe - způsoby provádění * trendy MeSH
- lidé MeSH
- protézy - design MeSH
- průřezové studie MeSH
- průzkumy zdravotní péče MeSH
- rizikové faktory MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- pozorovací studie MeSH
- Geografické názvy
- Evropa MeSH
Intra-abdominal infections (IAIs) are common surgical emergencies and have been reported as major contributors to non-trauma deaths in the emergency departments worldwide. The cornerstones of effective treatment of IAIs are early recognition, adequate source control, and appropriate antimicrobial therapy. Prompt resuscitation of patients with ongoing sepsis is of utmost important. In hospitals worldwide, non-acceptance of, or lack of access to, accessible evidence-based practices and guidelines result in overall poorer outcome of patients suffering IAIs. The aim of this paper is to promote global standards of care in IAIs and update the 2013 WSES guidelines for management of intra-abdominal infections.
- Klíčová slova
- Antibiotics, Intra-abdominal infections, Peritonitis, Sepsis,
- MeSH
- antibakteriální látky terapeutické užití MeSH
- chirurgové organizace a řízení trendy MeSH
- lidé MeSH
- management nemoci MeSH
- nitrobřišní infekce farmakoterapie chirurgie MeSH
- peritonitida farmakoterapie MeSH
- poranění břicha farmakoterapie chirurgie MeSH
- sepse farmakoterapie chirurgie MeSH
- směrnice jako téma * MeSH
- společnosti lékařské organizace a řízení trendy MeSH
- vyhodnocení orgánové dysfunkce MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
- Názvy látek
- antibakteriální látky MeSH